Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

LABLAB
Showing 8 of 31 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in STANDARD BIOTOOLS INC

CITADEL ADVISORS LLC holds 2.3M shares of LAB (STANDARD BIOTOOLS INC), worth $1.9M as of 2026-Q2. The position was increased (+91.7% shares). LAB represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$1.9M

Current Shares

2.3M

Total Value Change

+$1.8M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+91.7%
$1.9M0.0%$0.82
41
2026-Q1
Increased
1.2M
+13.8%
$1.1M0.0%$1.04
29
2025-Q4
Increased
1.1M
+120.4%
$1.4M0.0%$1.25
41
2025-Q3
Increased
488,443
+39.9%
$634,9760.0%$1.27
32
2025-Q2
New
349,160
-
$418,9920.0%$1.19
33
2025-Q1
Exited
0
-100.0%
$00.0%$1.14
0
2024-Q4
Increased
81,589
+24.2%
$142,7810.0%$1.77
19
2024-Q3
Decreased
65,670
-92.8%
$126,7430.0%$1.92
0

Other major holders of LAB: VIKING GLOBAL INVESTORS LP, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used